JPMorgan Chase reduced its holdings of GenScript Biotech (01548.HK) by approximately 33.751 million shares at approximately HK$32.74 per share.

Zhitong Finance APP has learned that the latest information from the Hong Kong Stock Exchange shows that on September 15, JPMorgan Chase reduced its holdings of GenScript Biotech (01548.HK) by 33.751017 million shares at HK$32.7394 per share, for a total amount of approximately HK$1.105 billion. After the reduction, its latest shareholding was approximately 129 million shares, with its latest shareholding ratio at 5.64%.